Zhejiang Medicine Co., Ltd.

Shanghai Stock Exchange 600216.SS

Zhejiang Medicine Co., Ltd. EBT Margin for the year ending December 31, 2023: 4.66%

Zhejiang Medicine Co., Ltd. EBT Margin is 4.66% for the year ending December 31, 2023, a -23.02% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Zhejiang Medicine Co., Ltd. EBT Margin for the year ending December 31, 2022 was 6.05%, a -52.08% change year over year.
Zhejiang Medicine Co., Ltd. EBT Margin for the year ending December 31, 2021 was 12.64%, a 8.79% change year over year.
Zhejiang Medicine Co., Ltd. EBT Margin for the year ending December 31, 2020 was 11.61%, a 105.82% change year over year.
Zhejiang Medicine Co., Ltd. EBT Margin for the year ending December 31, 2019 was 5.64%, a -12.71% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Shanghai Stock Exchange: 600216.SS

Zhejiang Medicine Co., Ltd.

CEO	Mr. Chun Lei Lu
IPO Date	Oct. 21, 1999
Location	China
Headquarters	168 Zhiyuan Middle Avenue
Employees	6,227
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products comprising sugars and hormones. The company was founded in 1997 and is headquartered in Shaoxing, China.

Key trends

Past 5 years